Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
Clinical trial NCT05932199 · RECRUITING
Trial details
- NCT number
- NCT05932199
- Sponsor
- Baylor College of Medicine
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-03
- Primary completion
- 2028-05-31
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.